LY-2959530

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLY-2959530
Drug Alias NameNOP receptor radioligandsnociceptin/orphanin FQ receptor PET ligandsLY-2959530
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionOpioid receptors modulators
TargetsOpioid receptors
Therapy Area/IndicationsAnxietyDepressionPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Mental Health (Nimh)
Active IndicationsN/A
Inactive IndicationsAnxietyDepressionPain

Other Information

ATC CodeN/A
Related LinksN/A